Directory · KY
Pharmaceutical Manufacturing in Cayman Islands
A register of firms and the professionals working at them in the Pharmaceutical Manufacturing sector based in Cayman Islands. Browse the public index, then filter or export on Kipplo.
Companies
4 on file
Quallent Pharmaceuticals Health, Llc
Quallent works with reputable manufacturers across the globe to deliver high-quality pharmaceuticals drugs.
11 to 50 staff
Bluewater Medical Supplies
Bluewater is a distributor of pharmaceuticals, surgical and medical supplies. We are the exclusive distributor for Medtronic MITG and AVP here in Cayman. We are an agent for Abbott Medical and carry many other name brands. We also rent durable medical equipment to patients on island.
1 to 10 staff
Dr Ashleys Limited
Dr Ashleys Limited is a Cayman Island registered pharmaceutical company with Registered office in Hong Kong corporate Center Latvija and USA. pharmaceutical trailblazer & a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for pharma and biotech companies. Dr Ashleys Limited’s capabilities span a wide range of development technologies and specialties—all backed by comprehensive industry knowledge and experience. Whether you need a partner in development or an experienced leader to navigate complex scale-up, Dr Ashleys is the final destination. Our deep knowledge of APIs manufacturing and processes is supported by a collaborative, consultative approach to ensure your expectations and milestones are met. Extensive portfolio of generic APIs. Our products cover a wide range of therapeutic classes, such as anti-cancer, anti-malarial, and pain management. Our APIs offering is supported by our network of GMP-compliant commercial manufacturing facilities in Europe and North America, to meet your global product requirements. Dr Ashleys Limited has made strategic partnership with leading manufacturing units worldwide to cater to the growing demands of the companies. We have a presence of more than 60 countries with a dedicated R&D facility at Riga in Latvia. Dr Ashleys Limited was born in the year 2012 as a pharmaceutical company to deliver world-class products. Over the years, Dr Ashleys has witnessed Exponential growth in meeting with clients complex demands of delivering world-class products as a reliable & trusted partner. Our vision is to be the world’s most trusted, reliable and innovative drug development and delivery partner by upholding the highest industry standards and exceeding customer expectations, while driving strong, sustained growth for the company. Our corporate responsibility (CR) strategy and commitments represent how we put our values into action to run our business and achieve
51 to 200 staff
Polaris Group
Polaris Group is a biopharmaceutical company dedicated to pioneering advanced therapies, primarily focusing on metabolic-related diseases. Our lead drug candidate, Pegargiminase (ADZODI), is presently advancing through the BLA-enabling stage for MPM and clinical development for other indications. Pegargiminase is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, soft tissue sarcoma, glioblastoma, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Pegargiminase is designed to disrupt cancer cell metabolism, providing a novel approach to treating a wide range of cancers heavily influenced by metabolic pathways. Our mission is to revolutionize the treatment of complex diseases like cancer by concentrating on their metabolic foundations, ultimately striving to enhance patient outcomes globally. For more information, please visit
201 to 500 staff
